Trial intelligence / Profile preview

Electromyographic comparison of adductor pollicis vs abductor digiti minimi during spontaneous recovery from rocuronium

jRCT1032250652Completed

Start
Jan 2026
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of rocuronium in None, sponsored by none. Primary endpoint: Time to TOF ratio 0.9. Started Jan 2026; status: completed.

02

Drugs

rocuronium

Beyond the preview

Go deeper on jRCT1032250652.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1032250652.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call